We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Lists Suspect Product Scenarios Requiring FDA Notification
Guidance Lists Suspect Product Scenarios Requiring FDA Notification
The FDA finalized guidance on suspect products and notification, describing when to file a report and adding examples of fraudulent activity that would warrant an alert to the agency, trading partners and wholesale distributors.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor